Position in DHR
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$3,269,017
+$1,380,412 QoQ
Shares Held
17,162
+72.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#736
of 2,099 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NUANCE INVESTMENTS, LLC holds $95,158,857 across 6 Diagnostics & Research names. DHR ranks #5 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | QGEN |
Qiagen N.V.
|
1,595,726 | $62,392,886 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
35,664 | $17,880,503 | |
| 3 | DGX |
Quest Diagnostics Inc
|
27,470 | $5,822,266 | |
| 4 | WAT |
Waters Corp /De/
|
10,762 | $4,036,180 | |
| 5 | DHR |
Danaher Corp /De/
This page
|
17,162 | $3,269,017 | |
| 6 | A |
Agilent Technologies, Inc.
|
13,235 | $1,758,005 |
All Filings in DHR
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,269,017 | 17,162 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,888,605 | 9,961 | Shares | Sole | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||